NEO NeoGenomics, Inc. - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jul 28, 2026
$18.47
· of 52w range
· above low
· to high
$7.0752w low
$20.0552w high
Market Cap (MRQ)
$2.36B
P/E
-77.9
Revenue
$727M
your badges
52W Range
$7–$20
Analyst Rating
BUY
Price Target
$20
P/E
-77.9
ROE
-12.8%
Net Profit Margin
-6.8%
Your badge strip is empty — pin a metric anywhere on this page.
NEO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$18.47
Market Cap (MRQ)
$2.36B
P/E
-77.9
Revenue
$727M
ROE
-12.8%
Debt/Equity (MRQ)
0.5
52W Range
$7–$20
NEO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About NeoGenomics, Inc. - Common Stock Company overview from Wikipedia
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.
## History
NeoGenomics first received state and national-level laboratory certifications in 2002. Three years later in 2005, the company developed a technical-only service model using FISH.
In 2013, the company launched its sequencing platform and was listed on the Nasdaq Stock Market as NEO. In 2014, NeoGenomics launched molecular tests including BTK and CALR mutation analysis.
In 2015, NeoGenomics acquired Clarient, Inc. and its subsidiary company, Clarient Diagnostic Services, Inc., a national cancer diagnostics laboratory with capabilities in immunohistochemistry for solid tumor cancers from GE Healthcare. Clarient is headquartered in Aliso Viejo, California; with an ancillary laboratory in Houston, Texas.
In November 2017, NeoGenomics established their first headquarters outside the United States in Rolle, Switzerland.
In September 2024, the District Court for the Middle District of North Carolina entered a permanent injunction against NeoGenomics’ accused RaDaR assay, which was preliminarily enjoined in December 2023.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
sectorHealth Care
industryHealth Care
employees2,500
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$727M2016-12-31 → 2025-12-31
Free Cash Flow$-22M2017-12-31 → 2025-12-31
Net margin-6.8%2019-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | NEO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -77.95Y avg ≈-73.2 | ≈-73.2 | · | · | |
| P/S (TTM) | 3.15Y avg ≈3.8 | ≈3.8 | 1.1 | Overvalued | |
| P/B (MRQ) | 3.05Y avg ≈2.2 | ≈2.2 | 2.4 | Fair value | |
| EV / EBITDA | -22.2 | · | · | · | |
| Price / FCF (TTM) | -321.25Y avg ≈-50.3 | ≈-50.3 | · | · | |
| Price / Cash Flow (TTM) | 107.25Y avg ≈-125.0 | ≈-125.0 | 13.5 | Overvalued | |
| EV / Revenue | 3.5 | · | · | · | |
| EV / FCF | -118.3 | · | · | · | |
| Price / Tangible Book (MRQ) | 4.65Y avg ≈40.2 | ≈40.2 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | NEO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 43.9%5Y avg ≈40.8% | ≈40.8% | 32.6% | Top tier | |
| Operating Margin (TTM) | -8.9%5Y avg ≈-20.7% | ≈-20.7% | 4.0% | Weak | |
| EBITDA Margin | -15.9%5Y avg ≈-20.7% | ≈-20.7% | 4.5% | Weak | |
| Pretax Margin (TTM) | -7.1%5Y avg ≈-15.6% | ≈-15.6% | 3.3% | Weak | |
| Net Profit Margin (TTM) | -6.8%5Y avg ≈-14.3% | ≈-14.3% | 2.4% | Weak | |
| ROA | -7.2%5Y avg ≈-5.1% | ≈-5.1% | 1.8% | Weak | |
| ROE | -12.8%5Y avg ≈-9.2% | ≈-9.2% | 3.3% | Weak | |
| ROIC | -9.6%5Y avg ≈-9.3% | ≈-9.3% | 5.0% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | NEO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.5 | · | 0.3 | High debt | |
| Current Ratio (MRQ) | 3.65Y avg ≈5.4 | ≈5.4 | 1.5 | Strong liquidity | |
| Quick Ratio | 3.65Y avg ≈3.9 | ≈3.9 | 1.2 | Strong liquidity | |
| Long-Term Debt / Equity (MRQ) | 0.5 | · | 0.4 | High debt |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | NEO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 10.1%5Y avg ≈10.4% | ≈10.4% | · | · | |
| Revenue CAGR 3Y | 12.6%5Y avg ≈11.2% | ≈11.2% | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | NEO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.55Y avg ≈0.4 | ≈0.4 | 1.6 | Weak | |
| Inventory Turnover | 14.95Y avg ≈13.7 | ≈13.7 | · | · | |
| Receivables Turnover | 4.75Y avg ≈4.6 | ≈4.6 | 8.4 | Weak | |
| Revenue / Employee | ≈$290.9K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
55.4%
Next Report
Oct 26, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Jul 27, 2026 | $0.05 | $0.03 | 51.1% |
| March 31, 2026 | $0.01 | $0.01 | — | |
| Dec. 31, 2025 | $0.06 | $0.04 | 53.5% | |
| Sept. 30, 2025 | $0.03 | $0.02 | 40.8% | |
| June 30, 2025 | $0.03 | $0.02 | 31.6% | |
| March 31, 2025 | $0.00 | $-0.01 | 100.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Cost of Revenue | $413M | $370M | $347M | $322M | $297M | $259M | $212M | $149M | $138M | $134M | $56M | $46M | |
| Gross Profit | $314M | $290M | $245M | $188M | $187M | $186M | $197M | $127M | $102M | $98M | $44M | $41M | |
| R&D Expense | $37M | $31M | $27M | $30M | $22M | $8M | $8M | $3M | $4M | $5M | $4M | $3M | |
| SG&A Expense | $273M | $260M | $243M | $243M | $221M | $144M | $128M | $85M | $70M | $64M | $34M | $24M | |
| Operating Expenses | $430M | $382M | $352M | $346M | $306M | $200M | $184M | $117M | $99M | $96M | $49M | $38M | |
| Operating Income | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | $10M | $3M | $2M | $-6M | $2M | |
| Interest Expense | · | · | $7M | $8M | $8M | $7M | $4M | $6M | $6M | · | $854.0K | $985.0K | |
| Interest Income | $9M | $18M | $17M | $6M | $3M | · | · | · | · | · | · | · | |
| Other Non-op | $296.0K | $-379.0K | $644.0K | $-213.0K | $-499.0K | $8M | $-5M | $14.0K | $-12.0K | $0 | $2M | $56.0K | |
| Pretax Income | $-110M | $-81M | $-97M | $-159M | $-15M | $-14M | $4M | $4M | $-3M | $-8M | $-4M | $1M | |
| Income Tax | $-2M | $-2M | $-9M | $-15M | $-7M | $-18M | $-4M | $1M | $-2M | $-2M | $-2M | $157.0K | |
| Net Income | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| EPS (Basic) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| Shares (Basic) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 108,579,000 | 100,470,000 | 85,618,000 | 79,426,000 | 77,542,000 | 60,526,000 | 53,483,000 | |
| Shares (Diluted) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 111,794,000 | 103,615,000 | 91,568,000 | 79,426,000 | 77,542,000 | 60,526,000 | 56,016,000 | |
| EBITDA | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | · | $2M | · | $-6M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $160M | $367M | $342M | $263M | $317M | $229M | $173M | $10M | $13M | $13M | $23M | $34M | |
| Receivables | $159M | $151M | $131M | $120M | $112M | $107M | $94M | $77M | $60M | $56M | $49M | $20M | |
| Inventory | $29M | $27M | $24M | $24M | $23M | $30M | $14M | $9M | $7M | $6M | $5M | $3M | |
| Prepaid Expense | $21M | $20M | $18M | $15M | $12M | $12M | $6M | $8M | $5M | $5M | $5M | $1M | |
| Other Current Assets | $7M | $12M | $8M | $8M | $8M | $5M | $3M | $561.0K | $1M | · | · | · | |
| Current Assets | $376M | $596M | $597M | $605M | $682M | $449M | $291M | $104M | $86M | $79M | $82M | $59M | |
| PP&E (Net) | $85M | $94M | $92M | $102M | $109M | $86M | $64M | $61M | $37M | $34M | $35M | $15M | |
| PP&E (Gross) | $294M | $284M | $250M | $234M | $219M | $179M | $133M | $111M | $77M | $61M | $61M | $35M | |
| Accum. Depreciation | $209M | $190M | $158M | $132M | $110M | $93M | $69M | $50M | $41M | $27M | $27M | $20M | |
| Goodwill | $524M | $523M | $523M | $523M | $527M | $211M | $199M | $198M | $147M | $147M | $147M | $3M | |
| Intangibles | $287M | $340M | $373M | $408M | $442M | $121M | $127M | $140M | $74M | $77M | $88M | $4M | |
| Other Non-current Assets | $9M | $6M | $5M | $5M | $7M | $5M | $3M | $3M | $891.0K | $174.0K | $129.0K | $141.0K | |
| Total Assets | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Accounts Payable | $23M | $22M | $20M | $21M | $18M | $25M | $20M | $18M | $10M | $17M | $12M | $6M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Liabilities | $88M | $301M | $96M | $90M | $87M | $73M | $64M | $61M | $36M | $38M | $40M | $15M | |
| Capital Leases | $63M | $61M | $68M | $69M | $72M | $42M | $24M | $5M | $5M | $5M | $5M | $5M | |
| Deferred Tax | $18M | $22M | $24M | $35M | $55M | $5M | $16M | $22M | $7M | · | $16M | $821.0K | |
| Other Non-current Liabilities | $12M | $12M | $13M | $13M | $14M | $4M | $4M | $3M | $283.0K | · | · | · | |
| Total Liabilities | $523M | $736M | $740M | $742M | $762M | $294M | $202M | $185M | $140M | $151M | $113M | $21M | |
| Long-term Debt | $342M | $541M | $538M | · | · | · | · | $102M | $97M | $98M | $55M | · | |
| Total Debt | $342M | $541M | · | · | · | $0 | · | · | $95M | · | $53M | · | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | $60.0K | |
| Retained Earnings | $-434M | $-326M | $-247M | $-159M | $-15M | $-7M | $-11M | $-19M | $-58M | $-52M | $-22M | $-19M | |
| Treasury Stock | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $-206.0K | $-2M | $-4M | $-638.0K | $10.0K | $-2M | $-579.0K | $274.0K | · | · | · | |
| Stockholders' Equity | $837M | $902M | $942M | $998M | $1.11B | $694M | $507M | $320M | $172M | $162M | $209M | $60M | |
| Liabilities + Equity | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Shares Outstanding | 128,989,152 | 128,145,333 | 127,369,142 | 126,913,992 | 124,107,500 | 112,075,474 | 104,781,236 | 94,465,440 | 80,462,574 | 78,571,158 | 75,820,307 | 60,242,818 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $26M | $20M | $16M | $16M | $16M | $7M | $5M | |
| Stock-based Comp | $41M | $33M | $25M | $25M | $22M | $10M | $10M | $7M | $6M | $5M | $3M | $641.0K | |
| Deferred Tax | $-3M | $-3M | $-10M | $-15M | $-7M | $-18M | $-4M | $2M | $-2M | $-2M | $-2M | · | |
| Amort. of Intangibles | $32M | $33M | $35M | $34M | $23M | $10M | $10M | $6M | $7M | $7M | $412.0K | $295.0K | |
| Restructuring | $0 | $7M | $11M | $5M | $0 | $0 | · | · | · | · | · | · | |
| Operating Cash Flow | $5M | $7M | $-2M | $-66M | $-27M | $1M | $23M | $45M | $18M | $21M | $6M | $9M | |
| CapEx | $27M | $41M | $29M | $31M | $64M | $29M | $20M | $14M | $14M | $8M | $2M | $4M | |
| Investing Cash Flow | $-12M | $13M | $77M | $517.0K | $-632M | $-159M | $-20M | $-140M | $-14M | · | · | · | |
| Stock Issued | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | $9M | $3M | · | · | $34M | |
| Net Stock Activity | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | · | · | · | · | · | |
| Financing Cash Flow | $-200M | $5M | $5M | $12M | $725M | $236M | $159M | $92M | $-4M | · | · | · | |
| Net Change in Cash | · | · | · | · | · | $78M | $163M | $-3M | $296.0K | $-11M | $-10M | $29M | |
| Taxes Paid | $515.0K | $207.0K | $175.0K | $180.0K | $148.0K | $246.0K | $319.0K | $-31.0K | $284.0K | $290.0K | · | · | |
| Free Cash Flow | $-22M | $-34M | $-31M | $-97M | $-91M | $-28M | $3M | · | $4M | · | $4M | · | |
| Levered FCF | · | · | $-37M | $-98M | $-94M | $-26M | $-5M | · | · | · | $4M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% | 41.8% | 48.1% | · | · | · | 875.1% | · | |
| Operating Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| Net Margin | -14.8% | -11.9% | -14.9% | -28.3% | -1.7% | 0.94% | 2.0% | · | · | · | -50.7% | · | |
| Pretax Margin | -15.2% | -12.2% | -16.4% | -31.3% | -3.1% | -3.2% | 0.89% | · | · | · | -89.8% | · | |
| EBITDA Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| ROA | -7.2% | -4.7% | -5.1% | -8.0% | -0.58% | 0.49% | 1.3% | · | -0.25% | · | -1.1% | · | |
| ROE | -12.8% | -8.7% | -9.3% | -14.3% | -0.74% | 0.61% | 1.6% | · | -0.50% | · | -1.9% | · | |
| ROIC | -9.6% | -6.2% | -10.4% | -14.3% | -5.9% | 0.60% | 5.6% | · | 0.21% | · | -1.2% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 | 6.1 | 4.5 | · | 2.4 | · | 2.5 | · | |
| Quick Ratio | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 | 4.6 | 4.2 | · | 2.1 | · | 1.8 | · | |
| Debt / Equity | 0.4 | 0.6 | · | · | · | 0.0 | · | · | 0.5 | · | 0.3 | · | |
| LT Debt / Equity | 0.4 | 0.4 | · | · | · | · | · | · | 0.5 | · | 0.2 | · | |
| Interest Coverage | · | · | -15.6 | -104.7 | -23.4 | -2.0 | 3.5 | · | · | · | -6.6 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.3 | 0.3 | 0.3 | 0.5 | 0.7 | · | · | · | 0.0 | · | |
| Inventory Turnover | 14.9 | 14.6 | 14.3 | 13.5 | 11.2 | 11.8 | 18.4 | · | 20.1 | · | 14.5 | · | |
| Receivables Turnover | 4.7 | 4.7 | 4.7 | 4.4 | 4.4 | 4.4 | 4.8 | · | · | · | 0.1 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.53 | $7.08 | $7.42 | $8.04 | $9.89 | $6.63 | $5.37 | · | $2.15 | · | $2.76 | · | |
| Revenue / Share | $5.68 | $5.22 | $4.71 | $4.10 | $4.04 | $3.98 | $3.95 | · | · | · | $0.08 | · | |
| Cash Flow / Share | $0.04 | $0.06 | $-0.02 | $-0.53 | $-0.22 | $0.01 | $0.23 | · | $0.23 | · | $0.11 | · | |
| Cash / Share | $1.25 | $2.88 | $2.70 | $2.12 | $2.83 | $2.18 | $1.83 | · | $0.16 | · | $0.31 | · | |
| EPS (TTM) | $-0.24 | $-0.24 | $-0.24 | $-0.24 | $-0.24 | $-0.24 | $-0.24 | $-0.24 | $-0.24 | $-0.24 | $-0.04 | $0.02 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 11.7% | 16.1% | 5.2% | 9.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.6% | 10.9% | 10.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Net Income TTM | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| Market Cap | $1.51B | $2.10B | $2.05B | $1.15B | $3.82B | $5.64B | $2.76B | · | $713M | · | $597M | · | |
| Enterprise Value | $1.69B | $2.27B | · | · | · | $5.41B | · | · | $795M | · | $626M | · | |
| P/E | -49.0 | -68.7 | -67.4 | -38.5 | -142.2 | -224.3 | -121.9 | -52.5 | -36.9 | -35.7 | -196.8 | 208.5 | |
| P/S | 2.1 | 3.2 | 3.5 | 2.2 | 7.9 | 12.7 | 6.8 | · | 3.0 | · | 119.3 | · | |
| P/B | 1.8 | 2.3 | 2.2 | 1.1 | 3.5 | 8.1 | 5.4 | · | 4.1 | · | 2.8 | · | |
| P / Tangible Book | 58.7 | 52.6 | 45.0 | 17.1 | 27.5 | 15.6 | · | · | · | · | · | · | |
| P / Cash Flow | 288.1 | 298.9 | -1051.4 | -17.4 | -143.1 | 3864.0 | 118.2 | · | 39.5 | · | 93.3 | · | |
| P / FCF | -69.2 | -61.7 | -66.9 | -11.8 | -42.1 | -204.1 | 827.3 | · | 164.0 | · | 142.8 | · | |
| EV / EBITDA | -14.6 | -24.7 | · | · | · | -386.8 | · | · | 342.1 | · | -111.1 | · | |
| EV / FCF | -77.6 | -66.8 | · | · | · | -195.9 | · | · | 182.9 | · | 149.9 | · | |
| EV / Revenue | 2.3 | 3.4 | · | · | · | 12.2 | · | · | 3.3 | · | 125.2 | · | |
| Earnings Yield | -2.0% | -1.5% | -1.5% | -2.6% | -0.70% | -0.45% | -0.82% | -1.9% | -2.7% | -2.8% | -0.51% | 0.48% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $202M | $187M | $190M | $188M | $181M | $168M | $172M | $168M | $165M | $156M | $156M | $152M | $147M | $137M | $139M | $129M | |
| Cost of Revenue | $110M | $106M | $107M | $107M | $104M | $95M | $95M | $93M | $92M | $91M | $88M | $90M | $87M | $82M | $82M | $80M | |
| Gross Profit | $92M | $81M | $83M | $80M | $77M | $73M | $77M | $75M | $72M | $65M | $68M | $62M | $60M | $55M | $57M | $49M | |
| R&D Expense | $11M | $10M | $9M | $9M | $9M | $10M | $8M | $8M | $8M | $8M | $7M | $5M | $8M | $7M | $7M | $7M | |
| SG&A Expense | $64M | $66M | $64M | $70M | $72M | $68M | $64M | $67M | $63M | $66M | $60M | $61M | $60M | $62M | $55M | $64M | |
| Operating Expenses | $102M | $99M | $97M | $107M | $125M | $101M | $96M | $96M | $94M | $96M | $86M | $87M | $90M | $90M | $83M | $88M | |
| Operating Income | $-10M | $-18M | $-13M | $-27M | $-48M | $-28M | $-18M | $-21M | $-22M | $-31M | $-19M | $-24M | $-30M | $-35M | $-26M | $-40M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | · | $-3M | $-3M | $2M | · | $139.0K | |
| Interest Income | $1M | $1M | $2M | $2M | $2M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | · | · | |
| Other Non-op | $-17.0K | $-12.0K | $84.0K | $-335.0K | $482.0K | $65.0K | $-431.0K | $317.0K | $-2.0K | $-263.0K | $124.0K | $-96.0K | $730.0K | $-114.0K | $-1.0K | $25.0K | |
| Pretax Income | $2M | $-18M | $-12M | $-26M | $-46M | $-26M | $-16M | $-18M | $-19M | $-28M | $-15M | $-21M | $-27M | $-34M | $-26M | $-40M | |
| Income Tax | $-412.0K | $-472.0K | $-3M | $740.0K | $-724.0K | $266.0K | $-804.0K | $-150.0K | $-375.0K | $-620.0K | $-960.0K | $-3M | $-2M | $-3M | $-3M | $-3M | |
| Net Income | $2M | $-17M | $-10M | $-27M | $-45M | $-26M | $-15M | $-18M | $-19M | $-27M | $-14M | $-19M | $-24M | $-31M | $-23M | $-37M | |
| Shares (Basic) | 129,628,000 | 129,166,000 | · | 128,415,000 | 127,949,000 | 127,376,000 | · | 126,953,000 | 126,405,000 | 126,111,000 | · | 125,687,000 | 125,356,000 | 125,026,000 | · | 124,425,000 | |
| Shares (Diluted) | 130,831,000 | 129,166,000 | · | 128,415,000 | 127,949,000 | 127,376,000 | · | 126,953,000 | 126,405,000 | 126,111,000 | · | 125,687,000 | 125,356,000 | 125,026,000 | · | 124,425,000 | |
| EBITDA | $-10M | $-18M | · | $-27M | $-48M | $-28M | · | $-21M | $-22M | $-31M | · | $-24M | $-30M | $-35M | · | $-40M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $146M | $146M | $160M | $164M | $155M | $346M | $367M | $362M | $355M | $332M | · | $306M | $289M | $276M | · | $266M | |
| Receivables | $175M | $167M | $159M | $155M | $153M | $151M | $151M | $151M | $147M | $140M | · | $133M | $125M | $119M | · | $112M | |
| Inventory | $27M | $30M | $29M | $28M | $34M | $30M | $27M | $24M | $23M | $20M | · | $24M | $25M | $24M | · | $24M | |
| Prepaid Expense | $24M | $24M | $21M | $22M | $23M | $23M | $20M | $18M | $17M | $19M | · | $19M | $17M | $16M | · | $17M | |
| Other Current Assets | $10M | $7M | $7M | $11M | $10M | $12M | $12M | $8M | $9M | $9M | · | $9M | $8M | $8M | · | $8M | |
| Current Assets | $381M | $374M | $376M | $382M | $393M | $574M | $596M | $590M | $584M | $574M | · | $587M | $585M | $585M | · | $603M | |
| PP&E (Net) | $81M | $84M | $85M | $85M | $85M | $90M | $94M | $93M | $92M | $88M | · | $95M | $100M | $103M | · | $107M | |
| PP&E (Gross) | · | · | $294M | · | · | · | $284M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $223M | $216M | $209M | $209M | $201M | $199M | $190M | $181M | $176M | $168M | · | $155M | $147M | $139M | · | $125M | |
| Goodwill | $524M | $524M | $524M | $524M | $524M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | · | $523M | |
| Intangibles | $271M | $279M | $287M | $294M | $302M | $331M | $340M | $348M | $356M | $365M | · | $382M | $391M | $399M | · | $417M | |
| Other Non-current Assets | $9M | $10M | $9M | $8M | $7M | $6M | $6M | $6M | $4M | $4M | · | $5M | $5M | $5M | · | $7M | |
| Total Assets | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Accounts Payable | $21M | $26M | $23M | $23M | $27M | $16M | $22M | $17M | $17M | $18M | · | $17M | $18M | $23M | · | $14M | |
| Current Liabilities | $106M | $85M | $88M | $98M | $100M | $280M | $301M | $296M | $290M | $77M | · | $93M | $95M | $87M | · | $85M | |
| Capital Leases | $65M | $61M | $63M | $64M | $67M | $60M | $61M | $62M | $63M | $65M | · | $62M | $65M | $67M | · | $70M | |
| Deferred Tax | $17M | $17M | $18M | $21M | $20M | $21M | $22M | $23M | $23M | $23M | · | $25M | $29M | $32M | · | $38M | |
| Other Non-current Liabilities | $862.0K | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $13M | · | $13M | $13M | $13M | · | $14M | |
| Total Liabilities | $567M | $518M | $523M | $536M | $540M | $713M | $736M | $733M | $727M | $717M | · | $731M | $739M | $735M | · | $743M | |
| Long-term Debt | · | · | $342M | · | · | · | $541M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $374M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-449M | $-451M | $-434M | $-424M | $-397M | $-352M | $-326M | $-310M | $-293M | $-274M | · | $-233M | $-214M | $-190M | · | $-136M | |
| Treasury Stock | $25M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $4.0K | $4.0K | $71.0K | $29.0K | $-56.0K | $-206.0K | $-643.0K | $-1M | $-1M | · | $-2M | $-3M | $-3M | · | $-5M | |
| Stockholders' Equity | $786M | $829M | $837M | $838M | $854M | $888M | $902M | $908M | $916M | $923M | $942M | $947M | $956M | $974M | $998M | $1.01B | |
| Liabilities + Equity | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Shares Outstanding | 127,917,946 | 129,653,642 | 128,145,333 | 128,885,101 | 128,681,713 | 128,356,327 | 128,145,333 | 128,061,944 | 127,851,113 | 127,434,786 | 127,369,142 | 127,261,476 | 127,144,418 | 127,200,491 | 126,913,992 | 126,562,037 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $8M | $10M | $8M | $10M | $12M | $11M | $8M | $0 | $9M | $8M | $7M | $0 | $6M | $5M | $5M | $4M | |
| Amort. of Intangibles | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | $9M | $8M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $1M | $2M | $3M | $5M | · | $0 | |
| Operating Cash Flow | $20M | $-8M | $1M | $9M | $20M | $-25M | $10M | $9M | $14M | $-26M | $18M | $-5M | $-2M | $-13M | $-4M | $-16M | |
| CapEx | $8M | $5M | $8M | $8M | $6M | $4M | $12M | $11M | $13M | $6M | $7M | $4M | $7M | $10M | $5M | $8M | |
| Investing Cash Flow | $-8M | $-5M | $-6M | $-277.0K | $-9M | $4M | $-5M | $-4M | $7M | $15M | $17M | $21M | $15M | $24M | $-1M | $-4M | |
| Stock Issued | $2M | $-338.0K | $431.0K | $765.0K | $-1M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $93.0K | $1M | $2M | $3M | |
| Net Stock Activity | · | $-338.0K | · | · | · | $949.0K | · | · | · | $816.0K | · | · | · | $1M | · | · | |
| Financing Cash Flow | $-12M | $-338.0K | $431.0K | $765.0K | $-202M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $64.0K | $1M | $2M | $3M | |
| Net Change in Cash | · | · | · | $9M | · | · | · | $7M | $23M | $-11M | · | $17M | $13M | $12M | · | $-18M | |
| Taxes Paid | $711.0K | $0 | $57.0K | $0 | $458.0K | $0 | $-112.0K | $143.0K | $87.0K | $89.0K | $0 | $0 | $175.0K | $0 | $25.0K | $26.0K | |
| Free Cash Flow | · | $-13M | · | · | · | $-30M | · | · | · | $-32M | · | · | · | $-23M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-33M | · | · | · | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.6% | 43.3% | · | 42.8% | 42.6% | 43.6% | · | 44.6% | 44.1% | 41.9% | · | 41.0% | 40.8% | 40.0% | · | 38.0% | |
| Operating Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| Net Margin | 1.1% | -9.2% | · | -14.4% | -24.9% | -15.4% | · | -10.5% | -11.3% | -17.3% | · | -12.2% | -16.6% | -22.4% | · | -28.6% | |
| Pretax Margin | 0.91% | -9.4% | · | -14.1% | -25.3% | -15.3% | · | -10.6% | -11.6% | -17.7% | · | -14.1% | -18.1% | -24.6% | · | -30.8% | |
| EBITDA Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| ROA | 0.16% | -1.2% | · | -1.8% | -3.0% | -1.6% | · | -1.1% | -1.1% | -1.6% | · | -1.1% | -1.4% | -1.7% | · | -2.0% | |
| ROE | 0.27% | -2.0% | · | -3.1% | -5.1% | -2.9% | · | -1.9% | -2.0% | -2.9% | · | -1.9% | -2.4% | -3.0% | · | -3.4% | |
| ROIC | -1.0% | -2.1% | · | -3.3% | -5.5% | -3.2% | · | -2.3% | -2.4% | -3.2% | · | -2.2% | -2.9% | -3.3% | · | -3.6% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 4.4 | · | 3.9 | 3.9 | 2.1 | · | 2.0 | 2.0 | 7.5 | · | 6.3 | 6.2 | 6.8 | · | 7.1 | |
| Quick Ratio | 3.0 | 3.7 | · | 3.3 | 3.1 | 1.8 | · | 1.7 | 1.7 | 6.2 | · | 4.7 | 4.4 | 4.6 | · | 4.4 | |
| Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -18.1 | · | 8.5 | 11.8 | · | · | -284.2 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 3.6 | 3.6 | · | 4.1 | 3.6 | 3.8 | · | 3.8 | 3.8 | 4.1 | · | 3.7 | 3.7 | 3.4 | · | 3.5 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.14 | $6.39 | · | $6.50 | $6.64 | $6.92 | · | $7.09 | $7.16 | $7.25 | · | $7.44 | $7.52 | $7.66 | · | $8.00 | |
| Revenue / Share | $1.54 | $1.45 | · | $1.46 | $1.42 | $1.32 | · | $1.32 | $1.30 | $1.24 | · | $1.21 | $1.17 | $1.10 | · | $1.03 | |
| Cash Flow / Share | · | $-0.06 | · | · | · | $-0.20 | · | · | · | $-0.21 | · | · | · | $-0.10 | · | · | |
| Cash / Share | $1.14 | $1.13 | · | $1.27 | $1.20 | $2.70 | · | $2.83 | $2.78 | $2.60 | · | $2.41 | $2.27 | $2.17 | · | $2.10 | |
| EPS (TTM) | $-0.24 | $-0.24 | · | $-0.24 | $-0.24 | $-0.24 | · | $-0.24 | $-0.24 | $-0.24 | · | $-0.24 | $-0.24 | $-0.24 | · | $-0.24 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $766M | $746M | · | $709M | $689M | $672M | · | $644M | $628M | $611M | · | $575M | $552M | $530M | · | $497M | |
| Net Income TTM | $-52M | $-99M | · | $-113M | $-104M | $-78M | · | $-78M | $-79M | $-84M | · | $-96M | $-115M | $-126M | · | $-163M | |
| Market Cap | $1.87B | $962M | · | $995M | $941M | $1.22B | · | $1.89B | $1.77B | $2.00B | · | $1.57B | $2.04B | $2.21B | · | $1.09B | |
| Enterprise Value | $2.10B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -60.8 | -30.9 | · | -32.2 | -30.5 | -39.5 | · | -61.5 | -57.8 | -65.5 | · | -51.2 | -67.0 | -72.5 | · | -35.9 | |
| P/S | 2.4 | 1.3 | · | 1.4 | 1.4 | 1.8 | · | 2.9 | 2.8 | 3.3 | · | 2.7 | 3.7 | 4.2 | · | 2.2 | |
| P/B | 2.4 | 1.2 | · | 1.2 | 1.1 | 1.4 | · | 2.1 | 1.9 | 2.2 | · | 1.7 | 2.1 | 2.3 | · | 1.1 | |
| P / Tangible Book | · | 37.2 | · | 50.3 | 33.5 | 35.6 | · | 50.5 | 48.3 | 55.8 | · | 36.6 | 47.8 | 42.4 | · | 14.9 | |
| P / Cash Flow | · | -118.2 | · | · | · | -48.1 | · | · | · | -77.3 | · | · | · | -174.5 | · | · | |
| EV / Revenue | 2.7 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1.6% | -3.2% | · | -3.1% | -3.3% | -2.5% | · | -1.6% | -1.7% | -1.5% | · | -1.9% | -1.5% | -1.4% | · | -2.8% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $727M | $661M | $592M | $510M | $484M |
| Gross Margin % | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% |
| Operating Margin % | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% |
| Net Income | $-108M | $-79M | $-88M | $-144M | $-8M |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.4 | 0.6 | · | · | · |
| Current Ratio | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 |
| Quick Ratio | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-22M | $-34M | $-31M | $-97M | $-91M |
Institutional owners (13F) 296 filers · $2.4B total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
296
Value held
$2.4B
New positions
58
Exited positions
38
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 58 (+9 vs prior Q) | 38 (+2 vs prior Q) | 100 (+22 vs prior Q) | 61 (-22 vs prior Q) | +19.6M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $304,469,400 | 20,868,362 | 12.94% | Shares |
| First Light Asset Management, LLC | $179,158,241 | 12,279,523 | 7.61% | Shares |
| VANGUARD GROUP INC | $162,621,455 | 13,828,355 | 6.91% | Shares |
| FIRST TRUST ADVISORS LP | $147,552,477 | 10,113,261 | 6.27% | Shares |
| Greenhouse Funds LLLP | $125,097,724 | 8,574,210 | 5.32% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $117,615,272 | 8,061,362 | 5.00% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $84,082,418 | 5,763,017 | 3.57% | Shares |
| STATE STREET CORP | $78,257,609 | 5,363,784 | 3.33% | Shares |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $73,501,000 | 5,037,787 | 3.12% | Shares |
| BRAIDWELL LP | $71,756,567 | 4,918,202 | 3.05% | Shares |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $61,886,083 | 4,342,883 | 2.63% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $50,558,727 | 3,465,300 | 2.15% | Call option |
| GEODE CAPITAL MANAGEMENT, LLC | $50,025,999 | 3,428,123 | 2.13% | Shares |
| MILLENNIUM MANAGEMENT LLC | $44,930,518 | 3,079,542 | 1.91% | Shares |
| TORONTO DOMINION BANK | $43,770,000 | 3,000,000 | 1.86% | Call option |
| LOOMIS SAYLES & CO L P | $37,025,291 | 2,537,717 | 1.57% | Shares |
| Driehaus Capital Management LLC | $36,604,049 | 2,508,845 | 1.56% | Shares |
| BANK OF AMERICA CORP /DE/ | $35,546,038 | 2,436,329 | 1.51% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $35,003,708 | 2,399,411 | 1.49% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $34,896,129 | 2,391,784 | 1.48% | Shares |
| AMERICAN CAPITAL MANAGEMENT INC | $32,648,145 | 2,237,707 | 1.39% | Shares |
| UBS Group AG | $32,581,659 | 2,233,150 | 1.38% | Call option |
| D. E. Shaw & Co., Inc. | $32,021,519 | 2,194,758 | 1.36% | Shares |
| SAMLYN CAPITAL, LLC | $31,096,207 | 2,131,337 | 1.32% | Shares |
| Aberdeen Group plc | $28,180,950 | 1,931,525 | 1.20% | Shares |
| MORGAN STANLEY | $27,693,709 | 1,898,128 | 1.18% | Shares |
| GOLDMAN SACHS GROUP INC | $22,859,028 | 1,566,760 | 0.97% | Shares |
| NORTHERN TRUST CORP | $22,456,651 | 1,539,181 | 0.95% | Shares |
| GLENMEDE TRUST CO NA | $22,141,579 | 1,517,586 | 0.94% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17,689,018 | 1,212,407 | 0.75% | Shares |
| SEGALL BRYANT & HAMILL, LLC | $15,850,518 | 1,086,396 | 0.67% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $12,685,640 | 869,475 | 0.54% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $12,149,312 | 832,715 | 0.52% | Shares |
| Glenmede Investment Management, LP | $12,057,018 | 1,561,790 | 0.51% | Shares |
| Connor, Clark & Lunn Investment Management Ltd. | $11,709,890 | 802,597 | 0.50% | Shares |
| Bank of New York Mellon Corp | $10,743,609 | 736,368 | 0.46% | Shares |
| CITIGROUP INC | $9,748,716 | 668,178 | 0.41% | Shares |
| PRINCIPAL FINANCIAL GROUP INC | $9,189,162 | 629,826 | 0.39% | Shares |
| HighMark Wealth Management LLC | $8,936,871 | 612,534 | 0.38% | Shares |
| Invesco Ltd. | $8,754,555 | 600,038 | 0.37% | Shares |
| UBS Group AG | $8,391,672 | 575,166 | 0.36% | Shares |
| JPMORGAN CHASE & CO | $8,363,938 | 581,091 | 0.36% | Shares |
| JUPITER ASSET MANAGEMENT LTD | $7,841,935 | 537,487 | 0.33% | Shares |
| Public Sector Pension Investment Board | $6,526,545 | 447,330 | 0.28% | Shares |
| Trexquant Investment LP | $6,358,074 | 435,783 | 0.27% | Shares |
| Nuveen, LLC | $6,172,300 | 423,050 | 0.26% | Shares |
| Granite Investment Partners, LLC | $5,181,507 | 355,141 | 0.22% | Shares |
| AMERIPRISE FINANCIAL INC | $4,625,865 | 317,057 | 0.20% | Shares |
| RHUMBLINE ADVISERS | $4,624,054 | 316,935 | 0.20% | Shares |
| Legal & General Group Plc | $4,317,503 | 295,922 | 0.18% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| IRS IDENTIFICATION NO. NeoGenomics, Inc. | April 12, 2007 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 52 insiders · 31 officers · 23 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Anthony P. Zook | Chief Executive Officer | April 1, 2026 M | 133,111 | 0 | 0 | $0 |
| Christopher M Smith | Chief Executive Officer | Feb. 23, 2025 M | 641,585 | 0 | 0 | $0 |
| Mark Mallon | Chief Executive Officer | March 1, 2022 A | 368,051 | 0 | 0 | $0 |
| Jeffrey Scott Sherman | Chief Financial Officer | Feb. 23, 2026 M | 220,009 | 0 | 0 | $0 |
| William Bonello | Chief Financial Officer | April 28, 2022 M | 191,548 | 0 | 0 | $0 |
| Sharon Virag | Chief Financial Officer | March 1, 2019 A | 10,944 | 0 | 0 | $0 |
| Vishal Sikri | President Advanced Diagnostics | Feb. 23, 2024 A | 127,716 | 0 | 0 | $0 |
| David Sholehvar | President, Clinical Services | Aug. 1, 2022 A | 43,216 | 0 | 0 | $0 |
| George Cardoza | President & COO, Lab Ops | March 2, 2022 F | 244,157 | 0 | 0 | $0 |
| Gina M Wallar | President, Pharma Services | March 1, 2022 A | 33,443 | 0 | 0 | $0 |
| Clive Morris | President of Inivata | Dec. 30, 2021 A | 41,280 | 0 | 0 | $0 |
| Robert J. Shovlin | President, Clinical Services | May 25, 2021 M | 150,101 | 0 | 0 | $0 |
| Warren Stone | Pres & Chief Operating Officer | Aug. 21, 2026 M | 181,078 | 0 | 1 | $-276,600 |
| Alicia C Olivo | EVP, GC & Business Development | Sept. 1, 2026 F | 90,875 | 0 | 2 | $-300,172 |
| Greg D Aunan | Chief Accounting Officer | Aug. 4, 2026 S | 5,153 | 0 | 1 | $-321,400 |
| Melody Harris | Chf Ops Off, Pres, Informatics | Feb. 23, 2025 M | 109,755 | 0 | 0 | $0 |
| Shashikant Kulkarni | Chief Scientific Officer | April 1, 2023 F | 82,673 | 0 | 0 | $0 |
| Cynthia J Dieter | Chief Accounting Officer | March 2, 2023 F | 29,765 | 0 | 0 | $0 |
| Douglas Matthew Brown | Chief Strategy Officer | April 1, 2022 A | 158,684 | 0 | 0 | $0 |
| Halley E Gilbert | Chief Legal Officer | March 1, 2022 A | 147,396 | 0 | 0 | $0 |
| Kathryn B Mckenzie | Chief Sustainability/Risk Ofcr | Jan. 11, 2022 M | 49,361 | 0 | 0 | $0 |
| Jennifer Balliet | VP and Chief Culture Officer | Dec. 30, 2021 A | 48,615 | 0 | 0 | $0 |
| Lawrence Martin Weiss | Chief Medical Officer | April 22, 2021 M | 130,847 | 0 | 0 | $0 |
| Denise E Pedulla | General Counsel | March 2, 2021 A | 60,643 | 0 | 0 | $0 |
| Steven G. Brodie | VP - Pharma Operations | Oct. 22, 2018 M | 45,953 | 0 | 0 | $0 |
| Steven A Ross | CIO | May 10, 2018 X | 4,500 | 0 | 0 | $0 |
| Maher Albitar | Chief Medical Officer | May 25, 2017 A | 60,692 | 0 | 0 | $0 |
| Mark Alan Machulcz | Vice President of Operations | Jan. 28, 2016 A | · | 0 | 0 | $0 |
| Robert H. Horel | Vice President GM PathLogic | Dec. 29, 2015 X | 51,218 | 0 | 0 | $0 |
| Robert P Gasparini | Chief Science Officer | May 22, 2014 X | 8,439 | 0 | 0 | $0 |
| Mark W Smits | Chief Commercial Officer | May 18, 2011 M | 0 | 0 | 0 | $0 |
| Carolyn S Starrett | Director | June 23, 2026 A | · | 0 | 0 | $0 |
| Lynn A. Tetrault | Director | June 15, 2026 S | 86,115 | 0 | 2 | $-118,824 |
| Marjorie C Green | Director | June 1, 2026 A | 22,964 | 0 | 0 | $0 |
| Neil Gunn | Director | June 1, 2026 A | 51,177 | 0 | 0 | $0 |
| Michael Aaron Kelly | Director | June 1, 2026 A | 67,086 | 0 | 0 | $0 |
| David Brian Perez | Director | June 1, 2026 A | 56,967 | 0 | 0 | $0 |
| John P. Kenny | Director | June 1, 2026 A | 5,893 | 0 | 0 | $0 |
| Stephen M Kanovsky | Director | June 1, 2026 A | 75,421 | 0 | 0 | $0 |
| Felicia Williams | Director | June 1, 2026 A | 30,237 | 0 | 0 | $0 |
| Elizabeth Floegel | Director | June 1, 2025 A | 23,590 | 0 | 0 | $0 |
| Alison L. Hannah | Director | June 1, 2025 M | 131,023 | 0 | 0 | $0 |
| Bruce K Crowther | Director | Aug. 10, 2023 A | 65,120 | 0 | 0 | $0 |
| Rachel A Stahler | Director | June 10, 2022 A | 21,335 | 0 | 0 | $0 |
| David Daly | Director | June 10, 2022 A | 17,179 | 0 | 0 | $0 |
| Kevin C Johnson | Director | Dec. 22, 2021 M | 37,398 | 0 | 0 | $0 |
| Douglas M Van Oort | Director | Aug. 1, 2021 F | 2,468,797 | 0 | 0 | $0 |
| Steven C Jones | Director | Jan. 7, 2021 M | 90,218 | 0 | 0 | $0 |
| Raymond R Hipp | Director | Nov. 16, 2020 S | 66,800 | 0 | 0 | $0 |
| William J Robison | Director | May 25, 2017 A | 183,348 | 0 | 0 | $0 |
| Michael T Dent | Director | Dec. 4, 2014 S | 1,384,150 | 0 | 0 | $0 |
| Peter M Peterson | Director | June 5, 2012 A | 34,500 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 51 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| PSCH · Invesco Exchange-Traded Fund Trust … | 1.27% | 123,482 SH | Oct. 1, 2026 | Daily |
| PTH · Invesco Exchange-Traded Fund Trust | 1.23% | 246,967 SH | Oct. 1, 2026 | Daily |
| XSMO · Invesco Exchange-Traded Fund Trust | 0.84% | 1,312,803 SH | Oct. 1, 2026 | Daily |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.71% | 601,468 NS | July 31, 2026 | N-PORT |
| IHF · iShares Trust | 0.34% | 250,331 SH | Sept. 11, 2026 | Daily |
| FYX · First Trust Exchange-Traded AlphaDE… | 0.27% | 239,159 NS | July 31, 2026 | N-PORT |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0.16% | 19,929 SH | Oct. 1, 2026 | Daily |
| NUSC · Nushares ETF Trust | 0.15% | 126,293 NS | July 31, 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.14% | 54,487 NS | July 31, 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.12% | 180,254 SH | Oct. 1, 2026 | Daily |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.12% | 89,895 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.11% | 104,297 SH | Aug. 19, 2026 | Daily |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.10% | 455,144 SH | Aug. 19, 2026 | Daily |
| ESML · iShares Trust | 0.09% | 146,435 SH | Sept. 11, 2026 | Daily |
| VIOV · VANGUARD ADMIRAL FUNDS | 0.09% | 116,046 SH | Aug. 19, 2026 | Daily |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0.09% | 33,444 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.08% | 3,367,792 SH | Sept. 11, 2026 | Daily |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.08% | 34,215 NS | July 31, 2026 | N-PORT |
| ISCG · iShares Trust | 0.07% | 40,558 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.06% | 63,019 NS | July 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.06% | 757,699 SH | Aug. 19, 2026 | Daily |
| SMDX · Tidal Trust III | 0.05% | 4,493 NS | July 31, 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.05% | 54,996 SH | Oct. 1, 2026 | Daily |
| VBK · VANGUARD INDEX FUNDS | 0.05% | 1,728,845 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.04% | 358,850 NS | July 31, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.03% | 388,986 SH | Aug. 19, 2026 | Daily |
| WSML · iShares Trust | 0.03% | 10,624 SH | Sept. 11, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.03% | 62,331 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.02% | 8,379 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 1,492,431 SH | Aug. 19, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.02% | 2,990,594 SH | Aug. 19, 2026 | Daily |
| IWO · iShares Trust | 0.01% | 115,979 SH | Sept. 11, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.01% | 344,253 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.01% | 15,340 NS | July 31, 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 12,627 SH | Aug. 19, 2026 | Daily |
| DCOR · Dimensional ETF Trust | 0.01% | 14,534 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 30,125 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 47,070 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 172,474 SH | Sept. 11, 2026 | Daily |
| TILT · FlexShares Trust | 0.00% | 4,536 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 35,356 SH | Sept. 10, 2026 | Daily |
| IXUS · iShares Trust | 0.00% | 56,854 SH | Sept. 11, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 4,136,535 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 10,236 SH | Aug. 19, 2026 | Daily |
| IJR · iShares Trust | · | 7,951,677 SH | Sept. 10, 2026 | Daily |
| IJT · iShares Trust | · | 716,232 SH | Sept. 9, 2026 | Daily |
| IJS · iShares Trust | · | 490,259 SH | Sept. 8, 2026 | Daily |
| IWN · iShares Trust | · | 1,129,992 SH | Sept. 11, 2026 | Daily |
| XJR · iShares Trust | · | 18,003 SH | Aug. 31, 2026 | Daily |
| ISCB · iShares Trust | · | 5,811 SH | Sept. 11, 2026 | Daily |
| SMLF · iShares Trust | · | 45,624 SH | Sept. 11, 2026 | Daily |
NEO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 16 analysts
BUY
Median target
$19.00
+2.9%
4 25.0%
Strong Buy
7 43.8%
Buy
5 31.2%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
9 analysts · 2026-10-02Mean target $19.72 +6.8%
Now
Current price $18.47
Low$16.00
Mean$19.72
High$35.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| NEO | $1.51B | -49.0 | 10.1% | -14.8% | -12.8% | 43.2% |
| OPCH | $5.00B | 25.1 | 13.0% | 3.7% | 15.4% | 19.3% |
| AVAH | $1.70B | 7.7 | 20.2% | 9.2% | 246.6% | 33.3% |
| GRDN | · | · | 17.9% | 3.4% | 24.8% | 20.2% |
| PRVA | $2.93B | 131.7 | 22.3% | 1.1% | 3.3% | · |
| MD | $1.77B | 11.0 | -4.9% | 8.6% | 20.3% | · |
| ADUS | · | 20.6 | 23.2% | · | · | · |
| WGS | · | · | · | · | · | · |
| ASTH | $1.21B | 53.9 | 56.4% | 0.71% | 3.0% | · |
| AMN | $606M | -6.4 | -8.5% | -3.5% | -15.3% | 28.3% |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Jul 28, 2026